Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Demonty

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Revue Medicale De Liege|August 15, 2000
[Guidelines for the management of patients with HIV infection. I. Adolescents and adults. Liege Working Group on HIV Infection]D Nkoghe, M Moutschen, J Demonty
Revue Medicale De Liege|August 30, 2003
[Prevention of malaria in the adult]P Léonard, M Moutschen, J Demonty
Revue Medicale De Liege|September 19, 2000
[Prevention strategies against malaria]P Delanaye, D Nkoghe, J Demonty
Revue Medicale De Liege|September 19, 2000
[Malaria: from diagnosis to curative treatment]P Delanaye, D Nkoghe, J Demonty
Revue Medicale De Liege|February 25, 2000
[Pharma-clinics. How I treat ... HIV infection. III. Non-nucleoside reverse transcriptase inhibitors]D Nkoghe, M Moutschen, P Léonard, et al.
Revue Medicale De Liege|January 16, 2002
[Pharma-clinics how I treat ... an HIV infection. IV. Protease inhibitors]P Léonard, D Nkoghe, M Moutschen, et al.
Revue Medicale De Liege|March 3, 1998
[Drug clinics. How I treat HIV infections. II. Nucleoside reverse transcriptase inhibitors]M Moutschen, D Nkoghe, P Léonard, et al.
Revue Medicale De Liege|January 31, 1998
[How I treat...an HIV infection. I. Pathologic basis for treatment choices]M Moutschen, D Nkoghe, P Léonard, et al.
Revue Medicale De Liege|February 25, 2000
[Pharma-clinics. The drug of the month. Nevirapine. Viramune]D Nkoghe, P Léonard, M Moutschen, et al.
The Journal of Infectious Diseases|November 1, 1990
Protective effects of polyclonal sera and of monoclonal antibodies active to Salmonella minnesota Re595 lipopolysaccharide during experimental endotoxemiaM Nys, J M Cloes, J Demonty, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Revue Medicale De Liege|August 15, 2000
[Guidelines for the management of patients with HIV infection. I. Adolescents and adults. Liege Working Group on HIV Infection]D Nkoghe, M Moutschen, J Demonty
Revue Medicale De Liege|August 30, 2003
[Prevention of malaria in the adult]P Léonard, M Moutschen, J Demonty
Revue Medicale De Liege|September 19, 2000
[Prevention strategies against malaria]P Delanaye, D Nkoghe, J Demonty
Revue Medicale De Liege|September 19, 2000
[Malaria: from diagnosis to curative treatment]P Delanaye, D Nkoghe, J Demonty
Revue Medicale De Liege|February 25, 2000
[Pharma-clinics. How I treat ... HIV infection. III. Non-nucleoside reverse transcriptase inhibitors]D Nkoghe, M Moutschen, P Léonard, et al.
Revue Medicale De Liege|January 16, 2002
[Pharma-clinics how I treat ... an HIV infection. IV. Protease inhibitors]P Léonard, D Nkoghe, M Moutschen, et al.
Revue Medicale De Liege|March 3, 1998
[Drug clinics. How I treat HIV infections. II. Nucleoside reverse transcriptase inhibitors]M Moutschen, D Nkoghe, P Léonard, et al.
Revue Medicale De Liege|January 31, 1998
[How I treat...an HIV infection. I. Pathologic basis for treatment choices]M Moutschen, D Nkoghe, P Léonard, et al.
Revue Medicale De Liege|February 25, 2000
[Pharma-clinics. The drug of the month. Nevirapine. Viramune]D Nkoghe, P Léonard, M Moutschen, et al.
The Journal of Infectious Diseases|November 1, 1990
Protective effects of polyclonal sera and of monoclonal antibodies active to Salmonella minnesota Re595 lipopolysaccharide during experimental endotoxemiaM Nys, J M Cloes, J Demonty, et al.
Pageof 6